X-box-binding protein 1-modified neural stem cells for treatment of Parkinson's disease

Neural Regeneration Research

Volumn 7, Issue 10, 2012, Pages 736-740

  Cui, Manhua ^a   Si, Lihui ^a   Xu, Tianmin ^a   Wang, Fengzhang ^b   Liu, Qun ^b  

^a THE SECOND HOSPITAL OF JILIN UNIVERSITY   (China)

^b THE FIRST HOSPITAL OF JILIN UNIVERSITY   (China)

Author keywords

Dopamine; Neural stem cells; Parkinson's disease; X box binding protein 1; synuclein

Indexed keywords

3, 4 DIHYDROXYPHENYLACETIC ACID; ALPHA SYNUCLEIN; DOPAMINE; TYROSINE 3 MONOOXYGENASE; UNCLASSIFIED DRUG; X BOX BINDING PROTEIN 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL SURVIVAL; CIRCLING BEHAVIOR; CONTROLLED STUDY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IMMUNOHISTOCHEMISTRY; MALE; NEURAL STEM CELL TRANSPLANTATION; NONHUMAN; PARKINSON DISEASE; PROTEIN EXPRESSION; RAT; SUBSTANTIA NIGRA; WESTERN BLOTTING;

EID: 84861326241     PISSN: 16735374     EISSN: 18767958     Source Type: Journal    
DOI: 10.3969/j.issn.1673-5374.2012.10.003     Document Type: Article

References (21)

1. Schröder M, Kaufman RJ. ER stress and the unfolded protein response. Mutat Res. 2005;569(1-2):29-63.
2. Lindholm D, Wootz H, Korhonen L. ER stress and neurodegenerative diseases. Cell Death Differ. 2006;13(3): 385-392.
3. Holtz WA, O'Malley KL. Parkinsonian mimetics induce aspects of unfolded protein response in death of dopaminergic neurons. J Biol Chem. 2003;278(21):19367-19377.
4. Yoshida H. Unconventional splicing of XBP-1 mRNA in the unfolded protein response. Antioxid Redox Signal. 2007;9(12): 2323-2333.
5. Iwakoshi NN, Pypaert M, Glimcher LH. The transcription factor XBP-1 is essential for the development and survival of dendritic cells. J Exp Med. 2007;204(10):2267-2275.
6. Souid S, Lepesant JA, Yanicostas C. The xbp-1 gene is essential for development in Drosophila. Dev Genes Evol. 2007;217(2): 159-167.
7. Sado M, Yamasaki Y, Iwanaga T, et al. Protective effect against Parkinson's disease-related insults through the activation of XBP1. Brain Res. 2009;1257:16-24.
8. Benavides-Piccione R, DeFelipe J. Distribution of neurons expressing tyrosine hydroxylase in the human cerebral cortex. J Anat. 2007;211(2):212-222.
9. Schmidt WJ, Alam M. Controversies on new animal models of Parkinson's disease pro and con: the rotenone model of Parkinson's disease (PD). J Neural Transm Suppl. 2006;(70): 273-276.
10. Xiong N, Huang J, Zhang Z, et al. Stereotaxical infusion of rotenone: a reliable rodent model for Parkinson's disease. PLoS One. 2009;4(11):e7878.
11. Reimold AM, Etkin A, Clauss I, et al. An essential role in liver development for transcription factor XBP-1. Genes Dev. 2000; 14(2):152-157.
12. Iwakoshi NN, Lee AH, Vallabhajosyula P, et al. Plasma cell differentiation and the unfolded protein response intersect at the transcription factor XBP-1. Nat Immunol. 2003:4(4):321-329.
13. Taupin P. BrdU immunohistochemistry for studying adult neurogenesis: paradigms, pitfalls, limitations, and validation. Brain Res Rev. 2007;53(1):198-214.
14. Auluck PK, Caraveo G, Lindquist S. α-Synuclein: membrane interactions and toxicity in Parkinson's disease. Annu Rev Cell Dev Biol. 2010;26:211-233.
15. Brown DR. Oligomeric alpha-synuclein and its role in neuronal death. IUBMB Life. 2010;62(5):334-339.
16. Jiang P, Gan M, Ebrahim AS, et al. ER stress response plays an important role in aggregation of a-synuclein. Mol Neurodegener. 2010;5:56.
17. The Ministry of Science and Technology of the People's Republic of China. Guidance Suggestions for the Care and Use of Laboratory Animals. 2006-09-30.
18. Huang J, Liu H, Gu W, et al. A delivery strategy for rotenone microspheres in an animal model of Parkinson's disease. B iom aterials. 2006;27(6):937-946.
19. Yang DB, Li YL, Yang LZ, et al. Experimental study of intraventricular neural stem cell transplantation for rat focal cerebral ischemia. Chinese Journal of Minimally Invasive Neurosurgery. 2006;11:27-29.
20. Aoki S, Inukai K, Sakurai M, et al. Monitoring of dopamine metabolism by in vivo voltammetry and high performance liquid chromatography in L-dopa-treated rats. Jpn J Pharmacol. 1987; 43(1):98-102.
21. Li H, Sun NL, Wang J, et al. Circadian expression of clock genes and angiotensin II type 1 receptors in suprachiasmatic nuclei of sinoaortic-denervated rats. Acta Pharmacol Sin. 2007;28(4): 484-492.